# Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer

> **NCT01561586** · PHASE3 · UNKNOWN · sponsor: **Korea Cancer Center Hospital** · enrollment: 374 (estimated)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Weekly cisplatin with RT
- **DRUG:** Tri-weekly cisplatin with RT

## Key facts

- **NCT ID:** NCT01561586
- **Lead sponsor:** Korea Cancer Center Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-03
- **Primary completion:** 2020-03
- **Final completion:** 2023-03
- **Target enrollment:** 374 (ESTIMATED)
- **Last updated:** 2019-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01561586

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01561586, "Tri-weekly Cisplatin Based Chemoradiation in Locally Advanced Cervical Cancer". Retrieved via AI Analytics 2026-07-04 from https://api.ai-analytics.org/clinical/NCT01561586. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*